Patents by Inventor Anie Azroyan

Anie Azroyan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11719711
    Abstract: The present disclosure relates to assays and methods for the detection of renal inflammation by measuring the level of P2Y14 and/or UDP-glucose in a sample from a subject, such as a urine sample. The present disclosure also relates to methods for the treatment of renal inflammation by administering a P2Y14 inhibitor.
    Type: Grant
    Filed: January 26, 2021
    Date of Patent: August 8, 2023
    Assignee: THE GENERAL HOSPITAL CORPORATION
    Inventors: Sylvie Breton, Dennis Brown, Anie Azroyan, Virna F. Cortez-Retamozo, Mikael Pittet
  • Publication number: 20210231688
    Abstract: The present disclosure relates to assays and methods for the detection of renal inflammation by measuring the level of P2Y14 and/or UDP-glucose in a sample from a subject, such as a urine sample. The present disclosure also relates to methods for the treatment of renal inflammation by administering a P2Y14 inhibitor.
    Type: Application
    Filed: January 26, 2021
    Publication date: July 29, 2021
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Sylvie Breton, Dennis Brown, Anie Azroyan, Virna F. Cortez-Retamozo, Mikael Pittet
  • Patent number: 10935556
    Abstract: The present disclosure relates to assays and methods for the detection of renal inflammation by measuring the level of P2Y14 and/or UDP-glucose in a sample from a subject, such as a urine sample. The present disclosure also relates to methods for the treatment of renal inflammation by administering a P2Y14 inhibitor.
    Type: Grant
    Filed: April 4, 2019
    Date of Patent: March 2, 2021
    Assignee: THE GENERAL HOSPITAL CORPORATION
    Inventors: Sylvie Breton, Dennis Brown, Anie Azroyan, Virna F. Cortez-Retamozo, Mikael Pittet
  • Publication number: 20200003791
    Abstract: The present disclosure relates to assays and methods for the detection of renal inflammation by measuring the level of P2Y14 and/or UDP-glucose in a sample from a subject, such as a urine sample. The present disclosure also relates to methods for the treatment of renal inflammation by administering a P2Y14 inhibitor.
    Type: Application
    Filed: April 4, 2019
    Publication date: January 2, 2020
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Sylvie Breton, Dennis Brown, Anie Azroyan, Virna F. Cortez-Retamozo, Mikael Pittet
  • Patent number: 10088489
    Abstract: The present disclosure relates to assays and methods for the detection of renal inflammation by measuring the level of P2Y14 and/or UDP-glucose in a sample from a subject, such as a urine sample. The present disclosure also relates to methods for the treatment of renal inflammation by administering a P2Y14 inhibitor.
    Type: Grant
    Filed: March 22, 2018
    Date of Patent: October 2, 2018
    Assignee: The General Hospital Corporation
    Inventors: Sylvie Breton, Dennis Brown, Anie Azroyan, Virna F. Cortez-Retamozo, Mikael Pittet
  • Publication number: 20180217167
    Abstract: The present disclosure relates to assays and methods for the detection of renal inflammation by measuring the level of P2Y14 and/or UDP-glucose in a sample from a subject, such as a urine sample. The present disclosure also relates to methods for the treatment of renal inflammation by administering a P2Y14 inhibitor.
    Type: Application
    Filed: March 22, 2018
    Publication date: August 2, 2018
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Sylvie Breton, Dennis Brown, Anie Azroyan, Virna F. Cortez-Retamozo, Mikael Pittet
  • Publication number: 20180136237
    Abstract: The present disclosure relates to assays and methods for the detection of renal inflammation by measuring the level of P2Y14 and/or UDP-glucose in a sample from a subject, such as a urine sample. The present disclosure also relates to methods for the treatment of renal inflammation by administering a P2Y14 inhibitor.
    Type: Application
    Filed: January 3, 2018
    Publication date: May 17, 2018
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Sylvie Breton, Dennis Brown, Anie Azroyan, Virna F. Cortez-Retamozo, Mikael Pittet
  • Patent number: 9891236
    Abstract: The present disclosure relates to assays and methods for the detection of renal inflammation by measuring the level of P2Y14 and/or UDP-glucose in a sample from a subject, such as a urine sample. The present disclosure also relates to methods for the treatment of renal inflammation by administering a P2Y14 inhibitor.
    Type: Grant
    Filed: November 7, 2014
    Date of Patent: February 13, 2018
    Assignee: THE GENERAL HOSPITAL CORPORATION
    Inventors: Sylvie Breton, Dennis Brown, Anie Azroyan, Virna F. Cortez-Retamozo, Mikael Pittet
  • Publication number: 20160274131
    Abstract: The present disclosure relates to assays and methods for the detection of renal inflammation by measuring the level of P2Y14 and/or UDP-glucose in a sample from a subject, such as a urine sample. The present disclosure also relates to methods for the treatment of renal inflammation by administering a P2Y14 inhibitor.
    Type: Application
    Filed: November 7, 2014
    Publication date: September 22, 2016
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: Sylvie Breton, Dennis Brown, Anie Azroyan, Virna F. Cortez-Retamozo, Mikael Pittet